190 related articles for article (PubMed ID: 33121472)
1. Elucidation of molecular links between obesity and cancer through microRNA regulation.
Dogan H; Shu J; Hakguder Z; Xu Z; Cui J
BMC Med Genomics; 2020 Oct; 13(1):161. PubMed ID: 33121472
[TBL] [Abstract][Full Text] [Related]
2. Integration of Omics Data to Identify Cancer-Related MicroRNA.
Cascione L
Methods Mol Biol; 2019; 1970():85-99. PubMed ID: 30963490
[TBL] [Abstract][Full Text] [Related]
3. Dynamic and Modularized MicroRNA Regulation and Its Implication in Human Cancers.
Shu J; Silva BVRE; Gao T; Xu Z; Cui J
Sci Rep; 2017 Oct; 7(1):13356. PubMed ID: 29042600
[TBL] [Abstract][Full Text] [Related]
4. Genome-scale MicroRNA target prediction through clustering with Dirichlet process mixture model.
Hakguder Z; Shu J; Liao C; Pan K; Cui J
BMC Genomics; 2018 Sep; 19(Suppl 7):658. PubMed ID: 30255782
[TBL] [Abstract][Full Text] [Related]
5. Identifying the key genes and microRNAs in colorectal cancer liver metastasis by bioinformatics analysis and in vitro experiments.
Zhang T; Guo J; Gu J; Wang Z; Wang G; Li H; Wang J
Oncol Rep; 2019 Jan; 41(1):279-291. PubMed ID: 30542696
[TBL] [Abstract][Full Text] [Related]
6. Comprehensive characterization of lncRNA-mRNA related ceRNA network across 12 major cancers.
Zhang Y; Xu Y; Feng L; Li F; Sun Z; Wu T; Shi X; Li J; Li X
Oncotarget; 2016 Sep; 7(39):64148-64167. PubMed ID: 27580177
[TBL] [Abstract][Full Text] [Related]
7. Biomarker microRNAs for prostate cancer metastasis: screened with a network vulnerability analysis model.
Lin Y; Chen F; Shen L; Tang X; Du C; Sun Z; Ding H; Chen J; Shen B
J Transl Med; 2018 May; 16(1):134. PubMed ID: 29784056
[TBL] [Abstract][Full Text] [Related]
8. MiRNA-BD: an evidence-based bioinformatics model and software tool for microRNA biomarker discovery.
Lin Y; Wu W; Sun Z; Shen L; Shen B
RNA Biol; 2018; 15(8):1093-1105. PubMed ID: 30081733
[TBL] [Abstract][Full Text] [Related]
9. MicroRNA expression and gene regulation drive breast cancer progression and metastasis in PyMT mice.
Nogales-Cadenas R; Cai Y; Lin JR; Zhang Q; Zhang W; Montagna C; Zhang ZD
Breast Cancer Res; 2016 Jul; 18(1):75. PubMed ID: 27449149
[TBL] [Abstract][Full Text] [Related]
10. Analysis of microarray-identified genes and microRNAs associated with drug resistance in ovarian cancer.
Zou J; Yin F; Wang Q; Zhang W; Li L
Int J Clin Exp Pathol; 2015; 8(6):6847-58. PubMed ID: 26261572
[TBL] [Abstract][Full Text] [Related]
11. In silico identification of key genes and signaling pathways targeted by a panel of signature microRNAs in prostate cancer.
Baruah MM; Sharma N
Med Oncol; 2019 Apr; 36(5):43. PubMed ID: 30937635
[TBL] [Abstract][Full Text] [Related]
12. Investigation of lipid metabolism dysregulation and the effects on immune microenvironments in pan-cancer using multiple omics data.
Hao Y; Li D; Xu Y; Ouyang J; Wang Y; Zhang Y; Li B; Xie L; Qin G
BMC Bioinformatics; 2019 May; 20(Suppl 7):195. PubMed ID: 31074374
[TBL] [Abstract][Full Text] [Related]
13. Common and Unique microRNAs in Multiple Carcinomas Regulate Similar Network of Pathways to Mediate Cancer Progression.
Niveditha D; Jasoria M; Narayan J; Majumder S; Mukherjee S; Chowdhury R; Chowdhury S
Sci Rep; 2020 Feb; 10(1):2331. PubMed ID: 32047181
[TBL] [Abstract][Full Text] [Related]
14. Integrated Dissection of lncRNA-Perturbated Triplets Reveals Novel Prognostic Signatures Across Cancer Types.
Wei Y; Zhou L; Huang Y; Guo D
Int J Mol Sci; 2020 Aug; 21(17):. PubMed ID: 32846981
[TBL] [Abstract][Full Text] [Related]
15. Roles of microRNAs in immunopathogenesis of non-alcoholic fatty liver disease revealed by integrated analysis of microRNA and mRNA expression profiles.
Zhang YJ; Hu Y; Li J; Chi YJ; Jiang WW; Zhang F; Liu YL
Hepatobiliary Pancreat Dis Int; 2017 Feb; 16(1):65-79. PubMed ID: 28119261
[TBL] [Abstract][Full Text] [Related]
16. MicroRNA-217: A regulator of human cancer.
Zhou S; Zhu C; Pang Q; Liu HC
Biomed Pharmacother; 2021 Jan; 133():110943. PubMed ID: 33254014
[TBL] [Abstract][Full Text] [Related]
17. MicroRNA dysregulational synergistic network: discovering microRNA dysregulatory modules across subtypes in non-small cell lung cancers.
Tran N; Abhyankar V; Nguyen K; Weidanz J; Gao J
BMC Bioinformatics; 2018 Dec; 19(Suppl 20):504. PubMed ID: 30577741
[TBL] [Abstract][Full Text] [Related]
18. Integration of genome scale data for identifying new players in colorectal cancer.
Sokolova V; Crippa E; Gariboldi M
World J Gastroenterol; 2016 Jan; 22(2):534-45. PubMed ID: 26811605
[TBL] [Abstract][Full Text] [Related]
19. Competing endogenous RNA network analysis identifies critical genes among the different breast cancer subtypes.
Chen J; Xu J; Li Y; Zhang J; Chen H; Lu J; Wang Z; Zhao X; Xu K; Li Y; Li X; Zhang Y
Oncotarget; 2017 Feb; 8(6):10171-10184. PubMed ID: 28052038
[TBL] [Abstract][Full Text] [Related]
20. Identification of a 5‑microRNA signature and hub miRNA‑mRNA interactions associated with pancreatic cancer.
Ma X; Tao R; Li L; Chen H; Liu Z; Bai J; Shuai X; Wu C; Tao K
Oncol Rep; 2019 Jan; 41(1):292-300. PubMed ID: 30365134
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
